Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 10/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 10/20 | 0.46 |
| ▸ | KDM1A | O60341 | 2/20 | 0.43 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.43 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.43 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.43 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.43 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.43 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.41 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31249463 | 0.92 | RAMP3 (0.44) | OPRM1OPRK1NMUR2NMUR1NTSR1 | |
| SCHEMBL31437168 | 0.91 | RAMP3 (0.47) | OPRM1OPRK1NMUR2NMUR1NTSR1 | |
| SCHEMBL31679150 | 0.89 | RAMP3 (0.47) | OPRM1OPRK1MAPK8MAPK9MAPK10 | |
| SCHEMBL31467772 | 0.89 | EPHA2 (0.41) | OPRM1OPRK1KDM1AEPHA2NTSR1 | |
| SCHEMBL30905097 | 0.88 | OPRM1 (0.42) | OPRM1OPRK1NMUR2NMUR1EPHA2 | |
| SCHEMBL5312915 | 0.87 | KDM1A (0.51) | KDM1AEPHA2 | |
| SCHEMBL5312908 | 0.87 | KDM1A (0.51) | KDM1AEPHA2 | |
| SCHEMBL31419820 | 0.87 | NTSR2 (0.44) | KDM1ANTSR1NTSR2 | |
| SCHEMBL11101521 | 0.87 | OPRK1 (0.48) | OPRM1OPRK1NMUR2NMUR1 | |
| SCHEMBL11101528 | 0.87 | OPRK1 (0.48) | OPRM1OPRK1NMUR2NMUR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025037993-A1 | DOSAGE FORM FOR PEPTIDE AGENTS | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |